HYPORENINEMIC HYPOALDOSTERONISM, SODIUM WASTING AND MINERALOCORTICOID-RESISTANT HYPERKALEMIA IN 2 PATIENTS WITH OBSTRUCTIVE UROPATHY

被引：8
|
作者：
PELLEYA, R [1 ]
OSTER, JR [1 ]
PEREZ, GO [1 ]
机构：
[1] VET ADM MED CTR,MED SERV,DIALYSIS UNIT IIIC,MIAMI,FL 33125
来源：
AMERICAN JOURNAL OF NEPHROLOGY | 1983年 / 3卷 / 04期
关键词：
D O I：
10.1159/000166717
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：223 / 227
页数：5
相关论文
共 50 条
  • [31] CARDIOVASCULAR EFFICACY OF SODIUM-GLUCOSE CO-TRANSPORTER-2 INHIBITORS AND ANGIOTENSIN RECEPTOR NEPRILYSIN INHIBITORS IN PATIENTS WITH HEART FAILURE ACCORDING TO MINERALOCORTICOID R
    Patoulias, Dimitrios
    Katsimardou, Alexandra
    Siskos, Fotios
    Imprialos, Konstantinos
    Stavropoulos, Konstantinos
    Toumpourleka, Maria
    Koutsampasopoulos, Konstantinos
    Papadopoulos, Christodoulos
    Doumas, Michael
    JOURNAL OF HYPERTENSION, 2022, 40 (SUPPL) : E70 - E70
  • [32] CARDIOVASCULAR EFFICACY OF SODIUM-GLUCOSE CO-TRANSPORTER-2 INHIBITORS AND ANGIOTENSIN RECEPTOR NEPRILYSIN INHIBITORS IN PATIENTS WITH HEART FAILURE ACCORDING TO MINERALOCORTICOID R
    Patoulias, Dimitrios
    Katsimardou, Alexandra
    Siskos, Fotios
    Imprialos, Konstantinos
    Stavropoulos, Konstantinos
    Toumpourleka, Maria
    Koutsampasopoulos, Konstantinos
    Papadopoulos, Christodoulos
    Doumas, Michael
    JOURNAL OF HYPERTENSION, 2022, 40 (SUPPL 1) : E70 - E70
  • [33] A significant dilemma in the treatment of heart failure patients with sacubitril/valsartan or sodium-glucose co-transporter 2 inhibitors: Whether to add mineralocorticoid receptor antagonists
    Patoulias, Dimitrios
    Papadopoulos, Christodoulos
    Stavropoulos, Konstantinos
    Imprialos, Konstantinos
    Boulmpou, Aristi
    Doumas, Michael
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2022, 41 (08) : 705 - 707
  • [34] Effect of mineralocorticoid receptor antagonist at baseline on the efficacy of sodium-glucose cotransporter-2 inhibitors in patients with heart failure: a meta-analysis of randomized controlled trials
    Arshad, Muhammad Sameer
    Ahmed, Aymen
    Ejaz, Arooba
    Ahmed, Warda
    Farooqi, Shaikh Muhammad Habibullah
    Memon, Muhammad Mustafa
    Shahid, Izza
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2022, 29 (14) : E334 - E337
  • [35] Sodium-glucose cotransporter 2 inhibition does not reduce hepatic steatosis in overweight, insulin-resistant patients without type 2 diabetes
    Marjot, Thomas
    Green, Charlotte J.
    Charlton, Catriona A.
    Cornfield, Thomas
    Hazlehurst, Jonathan
    Moolla, Ahmad
    White, Sarah
    Francis, Jane
    Neubauer, Stefan
    Cobbold, Jeremy Fl
    Hodson, Leanne
    Tomlinson, Jeremy W.
    JGH OPEN, 2020, 4 (03): : 433 - 440
  • [36] Meta-Analysis Assessing the Cardiovascular Efficacy of Sodium-Glucose CoTransporter-2 Inhibitors in Patients With Chronic Obstructive Pulmonary Disease
    Patoulias, Dimitrios
    Papadopoulos, Christodoulos
    Fragakis, Nikolaos
    Karagiannis, Asterios
    Doumas, Michael
    AMERICAN JOURNAL OF CARDIOLOGY, 2022, 174 : 188 - 189
  • [37] Association of Sodium-glucose Cotransporter 2 (SGLT-2) Inhibitor Use and Chronic Obstructive Pulmonary Disease (COPD) Outcomes Amongst Patients With Type 2 Diabetes Mellitus
    Geetha, H. Shanmugavel
    Gogtay, M. V.
    Perkit, N.
    Ravichandran, S.
    Sekar, A.
    Abraham, G. M.
    Trivedi, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [38] Effect of Treatment With Sodium-Glucose Cotransporter 2 Inhibitor on the Initiation of Continuous Positive Airway Pressure Therapy in Type 2 Diabetic Patients With Obstructive Sleep Apnea Syndrome
    Kusunoki, Masataka
    Hisano, Fumiya
    Wakazono, Naomi
    Tsutsumi, Kazuhiko
    Oshida, Yoshiharu
    Miyata, Tetsuro
    JOURNAL OF CLINICAL MEDICINE RESEARCH-CANADA, 2021, 13 (10-11): : 497 - 501
  • [39] Implications of Sodium-glucose Cotransporter 2 (SGLT-2) Inhibitor Use in the Incidence of Asthma and Chronic Obstructive Pulmonary Disease (COPD) Amongst Patients With Type 2 Diabetes Mellitus
    Geetha, H. Shanmugavel
    Gogtay, M. V.
    Perkit, N.
    Ravichandran, S.
    Sekar, A.
    Abraham, G. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [40] Limb-girdle muscular dystrophy type 2B causes HDL-C abnormalities in patients and statin-resistant muscle wasting in dysferlin-deficient mice
    Zoe White
    Zeren Sun
    Elodie Sauge
    Dan Cox
    Graham Donen
    Dmitri Pechkovsky
    Volker Straub
    Gordon A. Francis
    Pascal Bernatchez
    Skeletal Muscle, 12
12345